CD99 and prostate carcinoma: The human prostate cancer cell line PC3 is also used to analyse cancer cell TEM and metastatic pathways (Berish et al., 2018; Reymond et al., 2012); this cell line expresses CD99 and, upon CD99 depletion, also demonstrates increased spreading on an EC monolayer (Fig. S2).